Sulfonamides, Quantitative, Serum or Plasma
Also known as: SULFONA SP
Use
The Sulfonamides, Quantitative, Serum or Plasma test is used to optimize drug therapy and monitor patient adherence to sulfonamides. Quantitative analysis helps in ensuring the therapeutic levels of the drug in the body, minimizing toxicity, and assessing patient compliance.
Special Instructions
Not provided.
Limitations
The test result is nonspecific and may include multiple sulfonamides, metabolites, and other cross-reactive substances. The presence of interfering substances like acetaminophen, benzocaine, lidocaine, furosemide, thiazide diuretics, and para-aminobenzoic acid can affect the identity and quantity of the reported results.
New York Approved
Methodology
Other
Biomarkers
Sulfonamides
Analyte
LOINC Codes
- 4040-2 - Sulfonamide SerPl-mCnc
Result Turnaround Time
8-11 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.4 mL
Container
ARUP Standard Transport Tube
Collection Instructions
Separate from cells ASAP or within 2 hours of collection. Transfer serum or plasma to an ARUP Standard Transport Tube.
Causes for Rejection
Separator tubes.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 24 hours |
| Refrigerated | 3 months |
| Frozen | 3 months |
Other tests from different labs that may be relevant